Abstract
The detection of drug metabolites in hair is widely accepted as a proof for systemic uptake of the drug, unless the metabolites can be formed as artefacts. However, regarding synthetic cannabinoids, not much is known about mechanisms of incorporation into hair. For a correct interpretation concerning hair findings of these compounds and their metabolites, it is necessary to identify the different routes of incorporation and to assess their contribution to analytical findings. This study presents the results of the LC-ESI-MS/MS analysis of an authentic hair sample taken from a patient with a known history of heavy consumption of synthetic cannabinoids. In the authentic hair sample, 5F-PB-22 and AB-CHMINACA as well as their main metabolites 5F-PB-22 3-carboxyindole, PB-22 5-OH-pentyl, and AB-CHMINACA valine were detected in all segments, comprising segments grown in a time period where the substances had not been distributed on the ‘legal high’ market. To enable interpretation of the results regarding the distribution of the detected analytes along the hair shaft, the stability of 5F-PB-22 and AB-CHMINACA in hair matrix and under thermal stress was assessed. The stability tests revealed that the three ‘metabolites’ are also formed in externally contaminated hair after storage of the samples under different conditions. In addition, 5F-PB-22 3-carboxyindole and AB-CHMINACA valine were identified as degradation products in smoke condensate. Therefore, interpretation of ‘metabolite’ findings of compounds comprising chemically labile amide/ester bonds or 5-fluoro-pentyl side chains should be carried out with utmost care, taking into account the different mechanisms of formation and incorporation into hair.
Similar content being viewed by others
References
Moosmann B, Roth N, Auwärter V. Hair analysis for THCA-A, THC and CBN after passive in vivo exposure to marijuana smoke. Drug Test Anal. 2014;6(1–2):119–25.
Moosmann B, Roth N, Auwärter V. Hair analysis for Δ9-tetrahydrocannabinolic acid A (THCA-A) and Δ9-tetrahydrocannabinol (THC) after handling cannabis plant material. Drug Test Anal. 2016;8(1):129–33.
Moosmann B, Roth N, Auwärter V. Finding cannabinoids in hair does not prove cannabis consumption. Sci Rep. 2015;5:1–6. doi:10.1038/srep14906.
EMCDDA. New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015), (Lisbon, European Monitoring Centre for Drugs and Drug Addiction).
Moosmann B, Roth N, Hastedt M, Jacobsen-Bauer A, Pragst F, Auwärter V. Cannabinoid findings in children hair—what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Δ9-tetrahydrocannabinolic acid A concentrations. Drug Test Anal. 2015;7(5):349–57.
Hutter M, Moosmann B, Auwärter V, Neukamm MA. Hair analysis for JWH-018, JWH-122, and JWH-210 after passive in vivo exposure to synthetic cannabinoid smoke. Fore Toxicol. 2015;33(1):69–76.
Moosmann B, Valcheva T, Neukamm MA, Angerer V, Auwärter V. Hair analysis of synthetic cannabinoids: does the handling of herbal mixtures affect the analyst’s hair concentration? Fore Toxicol. 2015;33(1):37–44.
Hutter M, Kneisel S, Auwärter V, Neukamm MA. Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry. J Chromatogr B. 2012;903:95–101.
Saito T, Sasaki C, Namera A, Kurihara K, Inokuchi S. Experimental study on external contamination of hair by synthetic cannabinoids and effect of hair treatment. Fore Toxicol. 2015;33(1):155–8.
Pragst F, Balikova MA. State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta. 2006;370(1–2):17–49.
Pragst F, Broecker S, Hastedt M, Herre S, Andresen-Streichert H, Sachs H, et al. Methadone and illegal drugs in hair from children with parents in maintenance treatment or suspected for drug abuse in a german community. Ther Drug Monit. 2013;35(6):737–52.
Wang X, Drummer OH. Review: interpretation of drug presence in the hair of children. Forensic Sci Int. 2015;257:458–72.
Kerekes I, Yegles M, Grimm U, Wennig R. Ethyl glucuronide determination: head hair versus non-head hair. Alcohol Alcohol. 2009;44(1):62–6.
Kim J, In S, Park Y, Park M, Kim E, Lee S. Deposition of JWH-018, JWH-073 and their metabolites in hair and effect of hair pigmentation. Anal Bioanal Chem. 2013;405(30):9769–78.
Kim J, Park Y, Park M, Kim E, Yang W, Baeck S, et al. Simultaneous determination of five naphthoylindole-based synthetic cannabinoids and metabolites and their deposition in human and rat hair. J Pharm Biomed Anal. 2015;102(5):162–75.
Nakajima J, Takahashi M, Uemura N, Seto T, Fukaya H, Suzuki J, et al. Identification of N, N-bis(1-pentylindol-3-yl-carboxy)naphthylamine (BiPICANA) found in an herbal blend product in the Tokyo metropolitan area and its cannabimimetic effects evaluated by in vitro [35S]GTPγS binding assays. Fore Toxicol. 2015;33(1):84–92.
Hasegawa K, Wurita A, Minakata K, Gonmori K, Yamagishi I, Nozawa H, et al. Identification and quantitation of 5-fluoro-ADB, one of the most dangerous synthetic cannabinoids, in the stomach contents and solid tissues of a human cadaver and in some herbal products. Fore Toxicol. 2015;33(1):112–21.
Uchiyama N, Shimokawa Y, Kikura-Hanajiri R, Demizu Y, Goda Y, Hakamatsuka T. A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products. Fore Toxicol. 2015;33(2):244–59.
Wurita A, Hasegawa K, Minakata K, Gonmori K, Nozawa H, Yamagishi I, et al. Identification and quantitation of 5-fluoro-ADB-PINACA and MAB-CHMINACA in dubious herbal products. Fore Toxicol. 2015;33(2):213–20.
Thomsen R, Nielsen LM, Holm NB, Rasmussen HB, Linnet K. Synthetic cannabimimetic agents metabolized by carboxylesterases. Drug Test Anal. 2014;7(7):565–76.
Erratico C, Negreira N, Norouzizadeh H, Covaci A, Neels H, Maudens K, et al. In vitro and in vivo human metabolism of the synthetic cannabinoid AB‐CHMINACA. Drug Test Anal. 2015;7(10):866–76.
Castaneto MS, Wohlfarth A, Pang S, Zhu M, Scheidweiler KB, Kronstrand R, et al. Identification of AB-FUBINACA metabolites in human hepatocytes and urine using high-resolution mass spectrometry. Fore Toxicol. 2015;33(2):295–310.
Hutter M, Moosmann B, Kneisel S, Auwärter V. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism. J Mass Spectrom. 2013;48(7):885–94.
Tsujikawa K, Yamamuro T, Kuwayama K, Kanamori T, Iwata YT, Inoue H. Thermal degradation of a new synthetic cannabinoid QUPIC during analysis by gas chromatography–mass spectrometry. Fore Toxicol. 2014;32(2):201–7.
Moosmann B, Angerer V, Auwärter V. Inhomogeneities in herbal mixtures: a serious risk for consumers. Fore Toxicol. 2015;33(1):54–60.
Sasaki C, Saito T, Shinozuka T, Irie W, Murakami C, Maeda K, et al. A case of death caused by abuse of a synthetic cannabinoid N-1-naphthalenyl-1-pentyl-1H-indole-3-carboxamide. Fore Toxicol. 2015;33(1):165–9.
Auwärter V, Sporkert F, Hartwig S, Pragst F, Vater H, Diefenbacher A. Fatty acid ethyl esters in hair as markers of alcohol consumption. Segmental hair analysis of alcoholics, social drinkers, and teetotalers. Clin Chem. 2001;47(12):2114–23.
Cairns T, Hill V, Schaffer M, Thistle W. Removing and identifying drug contamination in the analysis of human hair. Forensic Sci Int. 2004;145(2–3):97–108.
Tsanaclis L, Nutt J, Bagley K, Bevan S, Wicks J. Differentiation between consumption and external contamination when testing for cocaine and cannabis in hair samples. Drug Test Anal. 2014;6(S1):37–41.
Tsanaclis L, Wicks JF. Differentiation between drug use and environmental contamination when testing for drugs in hair. Forensic Sci Int. 2008;176(1):19–22.
Cuypers E, Flinders B, Bosman I, Lusthof K, Van Asten A, Tytgat J, et al. Hair analysis: Contamination or use? The question finally resolved by imaging mass spectrometry? 52nd Annual meeting of the International Association of Forensic Toxicologists (TIAFT) (Buenos Aires); 2014.
Acknowledgments
The authors would like to thank Nadine Schiesel for her commitment in this project and her support in the laboratory work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The samples were obtained in the scope of the study ‘Spice II plus: New drugs of abuse: acute intoxication by synthetic cannabinoids and by new stimulants’ which was approved by the Ethics Committee of the University of Freiburg, Germany (EK-Freiburg 235/13 & 235/13_130683). Informed consent was given by all study participants. All further experiments in this study comply with current German laws.
Funding
This publication has been produced with the financial support of the ‘Prevention of and Fight against Crime’ program of the European Commission (JUST/2013/ISEC/DRUGS/AG/6421).
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Franz, F., Angerer, V., Hermanns-Clausen, M. et al. Metabolites of synthetic cannabinoids in hair—proof of consumption or false friends for interpretation?. Anal Bioanal Chem 408, 3445–3452 (2016). https://doi.org/10.1007/s00216-016-9422-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-016-9422-2